Risk factors for atherosclerotic cardiovascular disease (ASCVD) correlate with plasma lipoproteins-cholesterol concentrations [1–4], which can be modulated by cholesteryl ester transfer protein (CETP) activity and its inhibition [5]. This evidence concerns the gene CETP and atherosclerosis.